Healthcare | December 09, 2022
BASF and MedAccess complete shipment of 35 million interceptor G2 nets to fight malaria
35 million mosquito nets supplied to countries in sub-Saharan Africa through partners
35 million mosquito nets supplied to countries in sub-Saharan Africa through partners
GMP-compliant documentation of all manufacturing steps for cell and gene therapies
The initiative has garnered the distinction of being the world’s largest government owned telemedicine platform
Soluplus branded excipient play a critical role in enabling the drug development process for poorly soluble active pharmaceutical ingredients
Tambe has been with Biocon since 1997 and has held diverse leadership and operational roles.
Expanded capacity in Nansha, China will support mid-scale manufacturing to ensure a smooth transition between early-phase and large-scale commercial production
Results showed a statistically significant and clinically meaningful improvement in investigator-assessed progression-free survival
Phase-III trials were conducted for safety, and immunogenicity in around 3,100 subjects, in 14 trial sites across India (supported by BIRAC)
Shilpa Medicare Ltd's finished dosage form manufacturing facility, Unit IV, situated at Pharma SEZ, Jadcherla, Telangana has received Health Canada GMP approval
QS-21 in blockbuster Shingles vaccine, first vaccine approved for Malaria, promising RSV phase III candidate, and Covid-19 applications.
Subscribe To Our Newsletter & Stay Updated
